Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Brunet-Manquat

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|February 16, 2026
Design Differences and Usability Risks in GLP-1 Pen Injectors: A Comparative Study of a Generic and Reference DeviceLaurie Brunet-Manquat, Anne Combedazou, Claire Ramus, et al.
Expert Opinion on Drug Delivery|June 10, 2025
Feasibility of switching between different autoinjector designs: positive insights from formative Comparative Use Human Factors studiesChloé Stoll, Anne Combedazou, Laurie Brunet-Manquat, et al.
Expert Opinion on Drug Delivery|May 16, 2024
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug-device combination products: case study of a formative Comparative Use Human Factors studyLaurie Brunet-Manquat, Anne Combedazou, Bomby Ahuja, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|February 16, 2026
Design Differences and Usability Risks in GLP-1 Pen Injectors: A Comparative Study of a Generic and Reference DeviceLaurie Brunet-Manquat, Anne Combedazou, Claire Ramus, et al.
Expert Opinion on Drug Delivery|June 10, 2025
Feasibility of switching between different autoinjector designs: positive insights from formative Comparative Use Human Factors studiesChloé Stoll, Anne Combedazou, Laurie Brunet-Manquat, et al.
Expert Opinion on Drug Delivery|May 16, 2024
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug-device combination products: case study of a formative Comparative Use Human Factors studyLaurie Brunet-Manquat, Anne Combedazou, Bomby Ahuja, et al.
Pageof 1